| CTRI Number |
CTRI/2022/03/040919 [Registered on: 08/03/2022] Trial Registered Prospectively |
| Last Modified On: |
07/03/2022 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Ayurveda |
| Study Design |
Randomized, Parallel Group, Multiple Arm Trial |
|
Public Title of Study
|
Effect of Sadabhadradyam churna and Vrehddhatrayadi kwath in BPH. |
|
Scientific Title of Study
|
A clinical study to evaluate the efficacy of sadabhadradyam churna and vrehddhatrayaadi kwath in the management of benign prostratic hyperplasia(BPH). |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Sanjive Kumar Maithil |
| Designation |
PG Scholar |
| Affiliation |
M.M.M Govt.Ayurved college,Udaipur,Rajasthan. |
| Address |
PG Dept.of kayachikitsa
M.M.M Govt.Ayurved college,Udaipur,Rajasthan.
Udaipur RAJASTHAN 313001 India |
| Phone |
9549900972 |
| Fax |
|
| Email |
nir2006la@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
DR Indumati Sharma |
| Designation |
Asso.Professor and Guide |
| Affiliation |
M.M.M GOVT.AYURVED COLLEGE,UDAIPUR |
| Address |
PG Dept.of Kayachikitsa
M.M.M Govt.Ayurved College,Udaipur.
Udaipur RAJASTHAN 313001 India |
| Phone |
7976972310 |
| Fax |
|
| Email |
drindusharma4@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
DRINDUMATI SHARMA |
| Designation |
ASSO.PROFESSOR & GUIDE |
| Affiliation |
M.M.M GOVT.AYURVED COLLEGE,UDAIPUR |
| Address |
PG Dept.of kayachikitsa
M.M.M GOVT.AYURVED COLLEGE,UDAIPUR
RAJASTHAN 313001 India |
| Phone |
7976972310 |
| Fax |
|
| Email |
drindusharma4@gmail.com |
|
|
Source of Monetary or Material Support
|
| M.M.M Govt.Ayurved College,Udaipur,Rajasthan.
|
|
|
Primary Sponsor
|
| Name |
MMM GovtAyurved CollegeUdaipurRajasthan |
| Address |
M.M.M Govt.Ayurved College
Radaji Circle,Ambamata,Udaipur,Rajasthan.
PIN:313001 |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Sanjive Kumar Maithil |
Rajyavaidya Premshankar Sharma Ayurved Chikitsalaya |
0PD No:2, PG Dept. of kayachikitsa
Associated hospital,M.M.M Govt.Ayurved College,Udaipur,Rajasthan. Udaipur RAJASTHAN |
09549900972
nir2006la@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee,MMM Govt.Ayurved College,Udaipur,Rajasthan. |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:N400||Benign prostatic hyperplasia without lower urinary tract symptoms. Ayurveda Condition: VATASHTHILA, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Drug | Classical | | (1) Medicine Name: SADABHADRADYAM CHURNA, Reference: YOGRATNAKARA, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 2 Months, anupAna/sahapAna: No, Additional Information: - | | 2 | Intervention Arm | Drug | Classical | | (1) Medicine Name: VREHDDHATRAYAADI KWATH, Reference: BHAISHAJYA RATNAVALI, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 2 Months, anupAna/sahapAna: Yes(details: -SUGAR), Additional Information: - | | 3 | Intervention Arm | Drug | Classical | | (1) Medicine Name: SADABHADRADYAM CHURNA, Reference: YOGRATNAKARA, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 2 Months, anupAna/sahapAna: No, Additional Information: -(2) Medicine Name: VREHDDHATRAYAADI KWATH, Reference: BHAISHAJYA RATNAVALI, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 2 Months, anupAna/sahapAna: Yes(details: -SUGAR), Additional Information: - |
|
|
|
Inclusion Criteria
|
| Age From |
40.00 Year(s) |
| Age To |
75.00 Year(s) |
| Gender |
Male |
| Details |
1)Signs and symptoms of benign prostate hyperplasia
2)Residual urine <120 ml
|
|
| ExclusionCriteria |
| Details |
1)Residual urine >120 ml
2)Prostatic carcinoma
3)Complete urine retention |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
An Open list of random numbers |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Improvement in signs and symptoms of benign prostatic hyperplasia. |
2 months. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Improvement in signs and synptoms of benign prostatic hyperplasia. |
15 days,30 days and 45 days. |
|
|
Target Sample Size
|
Total Sample Size="30" Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
15/03/2022 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="2" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
NIL |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This is a interventional multiple arm clinical trial to evaluate the efficacy of sadabhadradyam churna and vrehddhatrayadi kwath in the management of benign prostatic hyperplasia.First Group is given sadabhadradyam churna ,second group is given vrehddhatrayadi kwath and third group is given both the medicines. |